Oxford Outcomes, Oxford, UK.
Vaccine. 2013 Jan 30;31(6):927-42. doi: 10.1016/j.vaccine.2012.12.010. Epub 2012 Dec 14.
This study uses a dynamic influenza transmission model to directly compare the cost-effectiveness of various policies of annual paediatric influenza vaccination in England and Wales, varying the target age range and level of coverage. The model accounts for both the protection of those immunised and the indirect protection of the rest of the population via herd immunity. The impact of augmenting current practice with a policy to vaccinate pre-school age children, on their own or with school age children, was assessed in terms of quality adjusted life years and health service costs. Vaccinating 2-18 year olds was estimated to be the most cost-effective policy in an incremental cost-effectiveness analysis, at an assumed annual vaccine uptake rate of 50%. The mean incremental cost-effectiveness ratios for this policy was estimated at £251/QALY relative to current practice. Paediatric vaccination would appear to be a highly cost-effective intervention that directly protects those targeted for vaccination, with indirect protection extending to both the very young and the elderly.
本研究使用动态流感传播模型,直接比较英格兰和威尔士年度儿童流感疫苗接种的各种政策的成本效益,这些政策的目标年龄范围和覆盖水平不同。该模型既考虑了免疫接种者的保护,也考虑了通过群体免疫对人群其余部分的间接保护。通过评估在当前实践基础上增加一项为学龄前儿童(单独或与学龄儿童一起)接种疫苗的政策,根据质量调整生命年和卫生服务成本来评估其影响。在增量成本效益分析中,假设每年疫苗接种率为 50%,估计为 2-18 岁儿童接种疫苗是最具成本效益的政策。该政策的平均增量成本效益比估计为每 QALY 251 英镑,与当前实践相比。儿童疫苗接种似乎是一种非常具有成本效益的干预措施,它可以直接保护目标人群,间接保护范围涵盖非常年幼的儿童和老年人。